Page last updated: 2024-08-23

silybin and Cachexia

silybin has been researched along with Cachexia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chaika, NV; Dasgupta, A; Goode, G; Gunda, V; King, R; Mehla, K; Mishra, A; Nagarajan, S; Rai, I; Shukla, SK; Singh, PK; Souchek, J; Vernucci, E; Yu, F	1

Other Studies

1 other study(ies) available for silybin and Cachexia

Article	Year
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget, 2015, Dec-01, Volume: 6, Issue:38 Topics: Animals; Antioxidants; Cachexia; Cell Line; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Glycolysis; Humans; Immunoblotting; Interleukin-6; Metabolome; Mice, Nude; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Silybin; Silymarin; STAT3 Transcription Factor; Tumor Burden; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays	2015

Article

Year

Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.

Oncotarget, 2015, Dec-01, Volume: 6, Issue:38

Topics: Animals; Antioxidants; Cachexia; Cell Line; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Glycolysis; Humans; Immunoblotting; Interleukin-6; Metabolome; Mice, Nude; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Silybin; Silymarin; STAT3 Transcription Factor; Tumor Burden; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays

2015